Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification and characterization of JunD missense mutants that lack menin binding

Abstract

Menin, the product of the MEN1 tumor suppressor gene, binds to the AP1 transcription factor JunD and represses JunD transcriptional activity. The effects of human or mouse JunD missense mutations upon menin interaction were studied by random and alanine scanning mutagenesis of the menin binding region of JunD (amino acids 1–70). JunD mutant proteins were tested for menin binding in a reverse yeast two-hybrid assay, and for transcriptional regulation by menin in AP1-reporter assays. Random mutagenesis identified two different mutations that disrupted menin interaction at mouse JunD amino acid 42 (G42E and G42R). Mutation G42A generated by alanine scanning did not affect menin binding, likely reflecting the conserved nature of this amino acid substitution. Furthermore, by size exclusion chromatography menin co-migrated with wild type JunD but not with the JunD mutant tested (G42E). Alanine scanning mutagenesis of residues 30–55 revealed two different amino acids, P41 and P44, of mouse JunD that were critical for interaction with menin. Mouse JunD missense mutants P41A, G42R, G42E and P44A failed to bind menin and also escaped menin's control over their transcriptional activity. At lower amounts of transfected menin, the transcriptional effect of menin on the mutants P41A, G42R and G42E was changed from repression to activation, similar to that with c-jun. In conclusion, a small N-terminal region of JunD mediates a key difference between JunD and c-jun, and a component of this difference is dependent on JunD binding to menin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ and Burns AL. . 1999 Cell 96: 143–152.

  • Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Green JS, Guru SC, Manickam P, Olufemi S, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL and Marx SJ. . 1997 Hum. Mol. Genet. 6: 1169–1175.

  • Alani R, Brown P, Binetruy B, Dosaka H, Rosenberg RK, Angel P, Karin M and Birrer MJ. . 1991 Mol. Cell Biol. 11: 6286–6295.

  • Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P. . 1987 Mol. Cell. Biol. 7: 2256–2266.

  • Angel P and Karin M. . 1991 Biochim. Biophys. Acta. 1072: 129–157.

  • Bartsch D, Kopp I, Bergenfelz A, Rieder H, Munch K, Jager K, Deiss Y, Schudy A, Barth P, Arnold R, Rothmund M and Simon B. . 1998 Eur. J. Endocrinol. 139: 416–420.

  • Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH and Thakker RV. . 1998 Am. J. Hum. Genet. 62: 232–244.

  • Berger I and Shaul Y. . 1991 Oncogene 6: 561–566.

  • Castellazzi M, Spyrou G, La Vista N, Dangy JP, Piu F, Yaniv M and Brun G. . 1991 Proc. Natl. Acad. Sci. USA 88: 8890–8894.

  • Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL and Marx SJ. . 1997 Science 276: 404–407.

  • Fromant M, Blanquet S and Plateau P. . 1995 Anal. Biochem. 224: 347–353.

  • Gobl AE, Berg M, Lopez-Egido JR, Oberg K, Skogseid B and Westin G. . 1999 Biochim. Biophys. Acta. 1447: 51–56.

  • Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delemer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M, Meyrier A, Caron P, Vantyghem M-C, Assayag M, Peix J-L, Pugeat M, Rohmer V, Vallotton M, Lenoir G, Gaudray P, Proye C, Conte-Devolx B, Chanson P, Shugart YY, Goldgar D, Murat A and Calender A. . 1998 Am. J. Hum. Genet. 63: 455–467.

  • Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS and Chandrasekharappa SC. . 1998 Proc. Natl. Acad. Sci. USA 95: 1630–1634.

  • Hai N, Aoki N, Matsuda A, Mori T and Kosugi S. . 1999 Eur. J. Endocrinol. 141: 475–480.

  • Hickman AB, Klein DC and Dyda FD. . 1999 Mol. Cell. 3: 23–32.

  • Hilberg F, Aguzzi A, Howells N and Wagner EF. . 1993 Nature 365: 179–181.

  • Johnson RS, van Lingen B, Papaioannou VE and Spiegelman BM. . 1993 Genes. Dev. 7: 1309–1317.

  • Kerr LD, Miller DB and Matrisian LM. . 1990 Cell 61: 267–278.

  • Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M and Roberts AB. . 1990 Mol. Cell. Biol. 10: 1492–1497.

  • Kim YS, Burns AL, Goldsmith PK, Heppner C, Park SY, Chandrasekharrapa SC, Collins FS, Spiegel AM and Marx SJ. . 1999 Oncogene 18: 5936–5942.

  • Lallemand D, Spyrou G, Yaniv M and Pfarr CM. . 1997 Oncogene 14: 819–830.

  • Lee W, Mitchell P and Tjian R. . 1987 Cell 49: 741–752.

  • Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Teh BT, Farnebo F, Phelan C, Hayward N, Larsson C, Pannett AAJ, Forbes SA, Duncan, Bassett JH and Thakker RV . (The European Consortium on MEN1). 1997 Hum. Mol. Genet. 6: 1177–1183.

  • Okazaki S, Ito T, Ui M, Watanabe T, Yoshimatsu K and Iba H. . 1998 Biochem. Biophys. Res. Commun. 250: 347–353.

  • Marx SJ. . 1998 In: The Genetic Basis of Human Cancer. Vogelstein B & Kinzler KW eds. McGraw Hill: New York pp. 489–506.

  • Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS and Chandrasekharappa SC. . 1999 Recent Prog. Horm. Res. 54: 397–439.

  • Metivier C, Piu F, Pfarr CM, Yaniv M, Loiseau L and Castellazzi M. . 1993 Oncogene 8: 2311–2315.

  • Mutch MG, Dilley WG, Sanjurjo F, DeBenedetti MK, Doherty GM, Wells Jr SA, Goodfellow PJ and Lairmore TC. . 1999 Hum. Mutat. 13: 175–185.

  • Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S and Yaniv M. . 1994 Cell 76: 747–760.

  • Poncin J, Abs R, Velkeniers B, Bonduelle M, Abramowicz M, Legros JJ, Verloes A, Meurisse M, Van Gaal L, Verellen C, Koulischer L and Beckers A. . 1999 Hum. Muta. 13: 54–60.

  • Schorpp-Kistner M, Wang ZQ, Angel P and Wagner EF. . 1999 EMBO J. 18: 934–948.

  • Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, Tranebjaerg L, Jorde R, Menon J, Khir A, Tan TT, Chan SP, Zaini A, Khalid BAK, Sandelin K, Thompson N, Brandi M-L, Warth M, Stock J, Leisti J, Cameron D, Shepard JJ, Oberg K, Nordenskjold M and Salmela P. . 1998 J. Clin. Endocrinol. Metab. 83: 2621–2626.

  • Thepot D, Weitzman JB, Barra J, Segretain D, Stinnakre MG, Babinet C and Yaniv M. . 2000 Development 127: 143–153.

  • Vidal M, Brachmann RK, Fattaey A, Harlow E and Boeke JD. . 1996 Proc. Natl. Acad. Sci. USA 93: 10315–10320.

  • Wisdom R. . 1999 Exp. Cell. Res. 253: 180–185.

Download references

Acknowledgements

We are grateful to Dr Regina Collins for support with cell culture. We thank Dr George Poy for DNA sequencing. We also thank Sylvia Park and Karl Bilimoria for technical protocols. J Knapp is a Howard Hughes Medical Institute – National Institutes of Health Scholar.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knapp, J., Heppner, C., Hickman, A. et al. Identification and characterization of JunD missense mutants that lack menin binding. Oncogene 19, 4706–4712 (2000). https://doi.org/10.1038/sj.onc.1203832

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203832

Keywords

This article is cited by

Search

Quick links